Markets

Market

News Details

(27/03/2026 14:51)

Biocon appoints Shreehas Tambe as CEO & MD; Kedar Upadhye Named CFO

Biocon Limited has appointed Shreehas Tambe as its Chief Executive Officer and Managing Director, effective April 1, 2026.

As the first CEO of the integrated Biocon, Tambe will lead the combined biosimilars and generics platform, enhancing the company’s scale and competitiveness in global markets.

The company also announced the appointment of Kedar Upadhye as Chief Financial Officer.

Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.